News

Swiss pharmaceutical company Roche has announced that a new antibiotic, zosurabalpin, is progressing to phase 3 testing.
Ready to upgrade your sunscreen routine this summer—for free? La Roche-Posay is offering a free sample of its award-winning Anthelios Face & Body Sunscreen, and it’s as easy as signing up while ...
Posay's Effaclar collection is the gold standard. Beloved for its lightweight textures, efficacious ingredients and friendly price point, it's no wonder the range is one of the brand's bestsellers. So ...
Swiss pharma company Roche (ROG.SW, RHHBY) is warning that its investment into the US could be at risk due to President Trump's executive order calling for reductions in drug prices. Yahoo Finance ...
Summer is fast approaching with the sun already having made a much welcome appearance in recent weeks. As such, many Brits have been looking to stock up on sun protection ahead of the warmer weather.
Roche said Monday it plans to invest up to $550 million and add hundreds of jobs over the next five years at its Indianapolis-based diagnostics unit. The Swiss pharmaceutical and diagnostics giant ...
BEAUTY fans can pick up a bestselling La Roche-Posay SPF worth £20 for just £3 ahead of the sunny weather. The clever TopCashback trick gives skincare lover's the opportunity to save £17 on the ...
Even as Roche makes a major investment pledge across its U.S. business, the Swiss pharmaceutical giant isn’t neglecting its chief markets in Asia. Roche is investing roughly 2.04 billion Chinese ...
Investors may be a bit calmer as optimism grows around trade deals, but markets should brace for further pain, according to one longtime strategist. David Roche, a former Morgan Stanley banker and ...
As part of this transformation, Roche Diagnostics – one of the world’s largest biotech companies and leading in-vitro diagnostics laboratory – is intensifying its engagement with Saudi Arabia.
Roche’s application to move Columvi up in the treatment sequence of relapsed or refractory diffuse large B-cell lymphoma (DLBCL) for transplant-ineligible patients and Johnson & Johnson’s bid ...
Ministry of Primary Industries (MPI) chief science advisor Dr John Roche has been appointed to the top job, which has been vacant since Dame Juliet Gerrard left in June 2024. Prime Minister ...